Variant report
Variant | esv3387838 |
---|---|
Chromosome Location | chr2:77646994-77649092 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559847886 | chr2:77647014-77647015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs145229638 | chr2:77647077-77647078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548773995 | chr2:77647097-77647098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs568687173 | chr2:77647116-77647117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531170657 | chr2:77647142-77647143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550971226 | chr2:77647169-77647170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs149141255 | chr2:77647177-77647178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs538215368 | chr2:77647181-77647182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558132282 | chr2:77647188-77647189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187751283 | chr2:77647192-77647193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534426770 | chr2:77647194-77647195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs369760001 | chr2:77647209-77647210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs146273403 | chr2:77647213-77647214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs191171140 | chr2:77647243-77647244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182182951 | chr2:77647264-77647265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs558710799 | chr2:77647282-77647283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs187767556 | chr2:77647287-77647288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556963928 | chr2:77647306-77647307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs192896973 | chr2:77647312-77647313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546176070 | chr2:77647313-77647314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184591045 | chr2:77647315-77647316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs113365138 | chr2:77647319-77647320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs528565352 | chr2:77647355-77647356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542328065 | chr2:77647389-77647390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs377757846 | chr2:77647443-77647444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531009962 | chr2:77647566-77647567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs551163030 | chr2:77647602-77647603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs571009421 | chr2:77647640-77647641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188276016 | chr2:77647682-77647683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs191974430 | chr2:77647716-77647717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs13404665 | chr2:77647731-77647732 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs371028225 | chr2:77647749-77647750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs148530177 | chr2:77647750-77647751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs534342458 | chr2:77647768-77647769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558283149 | chr2:77647789-77647790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs139399429 | chr2:77647823-77647824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs111968427 | chr2:77647849-77647850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs373452046 | chr2:77647908-77647909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs184398643 | chr2:77647920-77647921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs147097075 | chr2:77647947-77647948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs13004240 | chr2:77647954-77647955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs13004824 | chr2:77647955-77647956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148134077 | chr2:77647966-77647967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530231153 | chr2:77647993-77647994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs553338930 | chr2:77648038-77648039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112595851 | chr2:77648074-77648075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542290933 | chr2:77648101-77648102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs113093533 | chr2:77648104-77648105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189273558 | chr2:77648175-77648176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs76347527 | chr2:77648214-77648215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Epilepsy | 22083797 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:77645200-77647400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
2 | chr2:77647200-77647400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr2:77647400-77650600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |